Home > Insider Trading > Filing (0001140361-17-035053)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1561387	Health Insurance Innovations Inc.	HIIQ	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1366008	Sheldon Wang	C/O Health Insurance Innovations, Inc. 15438 N. Florida Ave., Suite 201 Tampa FL 33613	Chief Technology Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Class A Common Stock	Acquisiton	2017-09-07	893	$12.13	224,894	No	4	M	Direct
Class A Common Stock	Disposition	2017-09-07	326	$33.25	224,568	No	4	D	Direct
Class A Common Stock	Disposition	2017-09-07	567	$33.25	224,001	No	4	S	Direct
Class A Common Stock	Acquisiton	2017-09-07	5,000	$6.77	229,001	No	4	M	Direct
Class A Common Stock	Disposition	2017-09-07	1,037	$32.65	227,964	No	4	D	Direct
Class A Common Stock	Disposition	2017-09-07	3,963	$32.65	224,001	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	D	Direct
No	4	S	Direct
No	4	M	Direct
No	4	D	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Class A Common Stock	Stock Appreciation Rights	Disposition	2017-09-07	893	$0.00	893	$12.13
Class A Common Stock	Stock Appreciation Rights	Disposition	2017-09-07	5,000	$0.00	5,000	$6.77

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
5,107		2021-07-14	No	4	M	Direct
26,039		2021-05-25	No	4	M	Direct

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Class A Common Stock	Stock Appreciation Rights	$4.95		2022-07-01	20,000	20,000	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2022-07-01	20,000	20,000	Direct

Footnotes

Shares retained by the issuer to satisfy the exercise price of stock appreciation rights exercised by the reporting person.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $32.65 to $32.70, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth.
These stock-settled stock appreciation rights were previously granted under the Plan and are scheduled to vest in increments of 20%, 20%, 20%, and 40% on successive anniversary dates of the grant, subject to the terms of the plan and an award agreement under the plan.
These stock-settled stock appreciation rights were granted under the Issuer's Long Term Incentive Plan (the "Plan") and are vested as of the date of this Form 4.
These stock-settled stock appreciation rights were previously granted under the Plan and are scheduled to vest in increments of 25%, 25%, and 50% on successive anniversary dates of the grant, subject to the terms of the Plan and an award agreement under the Plan.